BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33947216)

  • 1. RAB1A regulates glioma cellular proliferation and invasion via the mTOR signaling pathway and epithelial-mesenchymal transition.
    Ren B; Wang L; Nan Y; Liu T; Zhao L; Ma H; Li J; Zhang Y; Ren X
    Future Oncol; 2021 Aug; 17(24):3203-3216. PubMed ID: 33947216
    [No Abstract]   [Full Text] [Related]  

  • 2. Rab1A knockdown represses proliferation and promotes apoptosis in gastric cancer cells by inhibition of mTOR/p70S6K pathway.
    Li Z; Li Y; Jia Y; Ding B; Yu J
    Arch Biochem Biophys; 2020 May; 685():108352. PubMed ID: 32240637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells.
    Xu H; Qian M; Zhao B; Wu C; Maskey N; Song H; Li D; Song J; Hua K; Fang L
    Oncol Rep; 2017 Mar; 37(3):1619-1626. PubMed ID: 28184936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer.
    Cheng Z; Shao X; Xu M; Wang J; Kuai X; Zhang L; Wu J; Zhou C; Mao J
    Oncol Rep; 2019 May; 41(5):2717-2728. PubMed ID: 30896866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway.
    Zhang T; Ji D; Wang P; Liang D; Jin L; Shi H; Liu X; Meng Q; Yu R; Gao S
    Cancer Lett; 2018 Feb; 415():151-163. PubMed ID: 29233656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A.
    Xu BH; Li XX; Yang Y; Zhang MY; Rao HL; Wang HY; Zheng XF
    Oncotarget; 2015 Aug; 6(25):20813-28. PubMed ID: 26308575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma.
    Liu PJ; Ye YX; Wang YX; Du JX; Pan YH; Fang XB
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6612-6620. PubMed ID: 31378903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rab1A is an mTORC1 activator and a colorectal oncogene.
    Thomas JD; Zhang YJ; Wei YH; Cho JH; Morris LE; Wang HY; Zheng XF
    Cancer Cell; 2014 Nov; 26(5):754-69. PubMed ID: 25446900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Rab1A is upregulated in human lung cancer and associated with tumor size and T stage.
    Wang X; Liu F; Qin X; Huang T; Huang B; Zhang Y; Jiang B
    Aging (Albany NY); 2016 Nov; 8(11):2790-2798. PubMed ID: 27902464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.
    Ma H; Li T; Tao Z; Hai L; Tong L; Yi L; Abeysekera IR; Liu P; Xie Y; Li J; Yuan F; Zhang C; Yang Y; Ming H; Yu S; Yang X
    J Cell Physiol; 2019 Feb; 234(2):1630-1642. PubMed ID: 30159893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dock1 promotes the mesenchymal transition of glioma and is modulated by MiR-31.
    Zhang B; Li H; Yin C; Sun X; Zheng S; Zhang C; Shi L; Liu Y; Lu S
    Neuropathol Appl Neurobiol; 2017 Aug; 43(5):419-432. PubMed ID: 26946516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forkhead box P3 regulates ARHGAP15 expression and affects migration of glioma cells through the Rac1 signaling pathway.
    Sun Z; Zhang B; Wang C; Fu T; Li L; Wu Q; Cai Y; Wang J
    Cancer Sci; 2017 Jan; 108(1):61-72. PubMed ID: 27862679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant gliomas induce and exploit astrocytic mesenchymal-like transition by activating canonical Wnt/β-catenin signaling.
    Lu P; Wang Y; Liu X; Wang H; Zhang X; Wang K; Wang Q; Hu R
    Med Oncol; 2016 Jul; 33(7):66. PubMed ID: 27236327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKAP alters tumor immune microenvironment and promotes glioma growth via Notch1 signaling.
    Gu G; Gao T; Zhang L; Chen X; Pang Q; Wang Y; Wang D; Li J; Liu Q
    J Exp Clin Cancer Res; 2019 Jul; 38(1):291. PubMed ID: 31277684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
    Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H
    Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of MicroRNA-375 Inhibits Proliferation and Migration in Gastric Cancer in Association With Autophagy-Mediated AKT/mTOR Signaling Pathways.
    Yuan KT; Li BX; Yuan YJ; Tan M; Tan JF; Dai WG; Feng WD; Zuo JD
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806499. PubMed ID: 30355273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitidine Chloride Is a Potential Alternative Therapy for Glioma Through Inducing Endoplasmic Reticulum Stress and Alleviating Epithelial-Mesenchymal Transition.
    Chen Z; Zhang J; Xue H; Qian M; Guo X; Gao X; Xu J; Qi Y; Sun X; Li G
    Integr Cancer Ther; 2020; 19():1534735419900927. PubMed ID: 32129091
    [No Abstract]   [Full Text] [Related]  

  • 18. The nuclear transporter importin-11 regulates the Wnt/β-catenin pathway and acts as a tumor promoter in glioma.
    Ni H; Ji D; Li J; Zhao Z; Zuo J
    Int J Biol Macromol; 2021 Apr; 176():145-156. PubMed ID: 33571591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rab1A promotes cancer metastasis and radioresistance through activating GSK-3β/Wnt/β-catenin signaling in nasopharyngeal carcinoma.
    Yang XZ; Chen XM; Zeng LS; Deng J; Ma L; Jin C; Wang R; Wang MH; Wen YF; Wu XL; Wang HY; Cui SZ
    Aging (Albany NY); 2020 Oct; 12(20):20380-20395. PubMed ID: 33068388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
    Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
    Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.